Table 1

Baseline characteristics of enrolled participants

Baseline characteristicIVIG (n=10)Placebo (n=8)All (n=18)
Age at randomisation (years)Median (IQR)5.55 (1.52–11.8)4.09 (2.71–9.64)4.09 (2.0–11.8)
SexMale4 (40%)4 (50%)8 (44.4%)
Female6 (60%)4 (50%)10 (55.6%)
EthnicityWhite8 (80%)8 (100%)16 (88.9%)
Asian1 (10%)0 (0%)1 (5.6%)
Missing1 (10%)0 (0%)1 (5.6%)
History of immunocompromiseNo9 (90%)7 (87.5%)16 (88.9%)
Missing1 (10%)1 (12.5%)2 (11.1%)
Previous diagnosis of encephalitisNo9 (90%)7 (87.5%)16 (88.9%)
Missing1 (10%)1 (12.5%)2 (11.1%)
History of encephalopathic illnessNo9 (90%)7 (87.5%)16 (88.9%)
Missing1 (10%)1 (12.5%)2 (11.1%)
Pre-existing diagnosis of epilepsyNo9 (90%)7 (87.5%)16 (88.9%)
Missing1 (10%)1 (12.5%)2 (11.1%)